| WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
TRIB2 |
TRIB2, TRB2: Tribbles homolog 2 |
1.432 |
Evidence |
|
| PTPN12 |
PTPN12: Tyrosine-protein phosphatase non-receptor type 12 |
SHC3 |
SHC3, NSHC, SHCC: SHC-transforming protein 3 |
1.432 |
Evidence |
|
| CHRM3 |
CHRM3: Muscarinic acetylcholine receptor M3 |
HTR2B |
HTR2B: 5-hydroxytryptamine receptor 2B |
1.432 |
Evidence |
|
| ZFHX1B |
Zinc finger homeobox protein 1b |
LEF1 |
LEF1: Lymphoid enhancer-binding factor 1 |
1.432 |
Evidence |
|
| ZNF271 |
IPI00099531 |
ZNF235 |
IPI00003503 |
1.432 |
Evidence |
|
| CHN2 |
CHN2, ARHGAP3, BCH: Beta-chimaerin |
DAB2 |
DAB2, DOC2: Disabled homolog 2 |
1.432 |
Evidence |
|
| MMP10 |
MMP10, STMY2: Stromelysin-2 precursor |
MMP8 |
CLG1, MMP8: Neutrophil collagenase precursor |
1.432 |
Evidence |
|
| APS |
SH2B2, APS: SH2B adapter protein 2 |
SOCS2 |
SOCS2, CIS2, SSI2, STATI2: Suppressor of cytokine signaling 2 |
1.432 |
Evidence |
|
| EIF3S10 |
EIF3S10, KIAA0139: Eukaryotic translation initiation factor 3 subunit 10 |
FKBP8 |
DKFZp686M22160: Putative uncharacterized protein DKFZp686M22160 (Fragment) |
1.432 |
Evidence |
|
| RFC4 |
RFC4: Replication factor C subunit 4 |
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
1.427 |
Evidence |
O
|
| RFC5 |
RFC5: Replication factor C subunit 5 |
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
1.427 |
Evidence |
|
| CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
CD40LG |
CD40LG, CD40L, TNFSF5, TRAP: CD40 ligand |
1.427 |
Evidence |
|
| RAC2 |
RAC2: Ras-related C3 botulinum toxin substrate 2 precursor |
VAV1 |
VAV1, VAV: Proto-oncogene vav |
1.427 |
Evidence |
|
| RAC2 |
RAC2: Ras-related C3 botulinum toxin substrate 2 precursor |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
1.427 |
Evidence |
|
| RAC2 |
RAC2: Ras-related C3 botulinum toxin substrate 2 precursor |
ARHGDIB |
ARHGDIB, GDIA2, GDID4, RAP1GN1: Rho GDP-dissociation inhibitor 2 |
1.427 |
Evidence |
O
|
| CTSL2 |
CTSL2, CATL2, UNQ268/PRO305, CTSU, CTSV: Cathepsin L2 precursor |
ATP1A1 |
ATP1A1: Sodium/potassium-transporting ATPase subunit alpha-1 precursor |
1.427 |
Evidence |
|
| DCP1B |
DCP1B: mRNA-decapping enzyme 1B |
EIF2C4 |
EIF2C4, AGO4, KIAA1567: Eukaryotic translation initiation factor 2C 4 |
1.427 |
Evidence |
|
| GOT2 |
GOT2: Aspartate aminotransferase, mitochondrial precursor |
CFL2 |
CFL2: Cofilin-2 |
1.427 |
Evidence |
|
| HMOX1 |
HMOX1, HO, HO1: Heme oxygenase 1 |
GIT2 |
IPI00238218 |
1.427 |
Evidence |
|
| FGFR2 |
IPI00218422 |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
1.427 |
Evidence |
|
| NOS2A |
NOS2A, NOS2: Nitric oxide synthase, inducible |
DLG1 |
IPI00218729 |
1.427 |
Evidence |
|
| GPR1 |
GPR1: Probable G-protein coupled receptor 1 |
RGS4 |
RGS4: Regulator of G-protein signaling 4 |
1.425 |
Evidence |
|
| SH2D1A |
SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A |
CD4 |
CD4: T-cell surface glycoprotein CD4 precursor |
1.425 |
Evidence |
|
| RGS16 |
RGS16, RGSR: Regulator of G-protein signaling 16 |
EDG7 |
EDG7, LPA3: Lysophosphatidic acid receptor Edg-7 |
1.425 |
Evidence |
|
| CXCR6 |
CXCR6, BONZO, STRL33, TYMSTR: C-X-C chemokine receptor type 6 |
RGS16 |
RGS16, RGSR: Regulator of G-protein signaling 16 |
1.425 |
Evidence |
|
- 
-